Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utility and adoption of CYP2D6 and CYP2C19 genotyping and its translation into psychiatric clinical practice.

Acta psychiatrica Scandinavica - 1 Mar 2012

Jürgens G, Jacobsen C B, Rasmussen H B, Werge T, Nordentoft M, Andersen S E

Abstract excerpt

OBJECTIVE: To describe clinical utility and adoption of routinely offered CYP2D6 and CYP2C19 genotyping (CYP test) in daily clinical practice of a psychiatric centre. METHOD: We described psychiatrists translations of CYP test results in patients with genotypes indicating poor or ultrarapid metabolizer status and treated with at least one CYP-dependent drug based on a retrospective review of medical records....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Attitude of Health Personnel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C19

Share to Cytochrome P-450 CYP2D6

Share to Mental Disorders

Share to Pharmaceutical Preparations

Share to Practice Patterns, Physicians'

Share to Psychiatry

Source

Identifiers

PMID: 22128793
DOI: 10.1111/j.1600-0447.2011.01802.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utility and adoption of CYP2D6 and CYP2C19 genotyping and its translation into psychiatric clinical practice.PMID 22128793Read ↗

Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guidelines and a Commercial Pharmacogenetics Laboratory in Genotype to Phenotype Interpretations For Patients Utilizing PsychotropicsSemantic proximity Read ↗

Towards the implementation ofCYP2D6andCYP2C19genotypes in clinical practice: Update and report from a pharmacogenetic service clinicSemantic proximity Read ↗

Clinical Guidelines for Psychiatrists for the Use of Pharmacogenetic Testing for CYP450 2D6 and CYP450 2C19Semantic proximity Read ↗

Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult ClinicSemantic proximity Read ↗

Implementation of CYP2C19 and CYP2D6 genotyping to guide antidepressant use in a large rural health system.Semantic proximity Read ↗

Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting.Semantic proximity Read ↗

Availability of CYP2D6 genotyping results in general practitioner and community pharmacy medical records.Semantic proximity Read ↗

Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribingSemantic proximity Read ↗

Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication.Semantic proximity Read ↗

Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19.Semantic proximity Read ↗

AmpliChip CYP450 test: personalized medicine has arrived in psychiatry.Semantic proximity Read ↗

How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.